0001117057 false Q3 --12-31 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 1 1 On November 26, 2025, Bozhuang entered into a Share Purchase Agreements with shareholders of Hubei Shengsili, to acquire 67% of the equity interests in Hubei Shengsili for consideration of $145. 0001117057 2026-07-01 2026-09-30 0001117057 2026-08-11 2026-08-11 0001117057 2026-08-11 0001117057 plag:SalesAgreementMember us-gaap:SubsequentEventMember 2026-10-02 0001117057 2026-01-01 2026-09-30 0001117057 country:CN 2025-12-31 0001117057 country:CN 2026-09-30 0001117057 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersFMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersEMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersDMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersCMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersBMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersAMember 2025-01-01 2025-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember plag:CustomersEMember 2026-01-01 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomerDMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomerCMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomersBMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomersAMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001117057 2025-01-01 2025-09-30 0001117057 2025-07-01 2025-09-30 0001117057 plag:PlanetGreenHoldingsCorpMember us-gaap:CommonStockMember 2026-09-30 0001117057 plag:EquityIncentivePlanMember 2025-01-01 2025-12-31 0001117057 plag:EquityIncentivePlanMember 2025-08-29 0001117057 plag:PlanetGreenHoldingsCorpMember 2025-09-09 0001117057 plag:PlanetGreenHoldingsCorpMember srt:BoardOfDirectorsChairmanMember 2025-09-09 0001117057 2025-12-31 0001117057 plag:BankOverdraftMember 2025-12-31 0001117057 plag:BankOverdraftMember 2026-09-30 0001117057 plag:MrWeiJinMember 2025-12-31 0001117057 plag:MrWeiJinMember 2026-09-30 0001117057 plag:MrWeiJinMember 2026-01-01 2026-09-30 0001117057 plag:ChajiaduoSupplyChainHubeiCoLtdMember 2025-12-31 0001117057 plag:ChajiaduoSupplyChainHubeiCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:HubeiTaiheMember 2026-09-24 2026-09-24 0001117057 plag:HubeiKeqibangMember 2026-09-24 0001117057 plag:HubeiShengsiliBiotechnologyCoLtdMember 2025-11-26 2025-11-26 0001117057 plag:HubeiShengsiliBiotechnologyCoLtdMember 2025-11-26 0001117057 plag:HubeiKeqibangMember 2026-09-30 0001117057 plag:ShengsiliMember 2026-09-30 0001117057 plag:ShengsiliMember 2026-01-01 2026-09-30 0001117057 plag:HubeiKeqibangMember 2026-01-01 2026-09-30 0001117057 plag:ShengsiliMember 2025-12-31 0001117057 us-gaap:RelatedPartyMember 2025-12-31 0001117057 us-gaap:RelatedPartyMember 2026-09-30 0001117057 plag:MrYangYongMember 2026-09-30 0001117057 plag:MrYangYongMember 2026-01-01 2026-09-30 0001117057 plag:MsYeZhangMember 2025-12-31 0001117057 plag:MsYeZhangMember 2026-01-01 2026-09-30 0001117057 plag:MsHuiyingJinMember 2025-12-31 0001117057 plag:MsHuiyingJinMember 2026-09-30 0001117057 plag:MsHuiyingJinMember 2026-01-01 2026-09-30 0001117057 plag:MsLuojiePuMember 2025-12-31 0001117057 plag:MsLuojiePuMember 2026-01-01 2026-09-30 0001117057 plag:MrBinZhouMember 2025-12-31 0001117057 plag:MrBinZhouMember 2026-09-30 0001117057 plag:MrBinZhouMember 2026-01-01 2026-09-30 0001117057 us-gaap:TrademarksMember 2025-12-31 0001117057 us-gaap:TrademarksMember 2026-09-30 0001117057 us-gaap:SoftwareDevelopmentMember 2025-12-31 0001117057 us-gaap:SoftwareDevelopmentMember 2026-09-30 0001117057 us-gaap:UseRightsMember 2025-12-31 0001117057 us-gaap:UseRightsMember 2026-09-30 0001117057 us-gaap:VehiclesMember 2025-12-31 0001117057 us-gaap:VehiclesMember 2026-09-30 0001117057 us-gaap:OfficeEquipmentMember 2025-12-31 0001117057 us-gaap:OfficeEquipmentMember 2026-09-30 0001117057 us-gaap:MachineryAndEquipmentMember 2025-12-31 0001117057 us-gaap:MachineryAndEquipmentMember 2026-09-30 0001117057 us-gaap:BuildingMember 2025-12-31 0001117057 us-gaap:BuildingMember 2026-09-30 0001117057 plag:OverThreeYearsMember 2025-12-31 0001117057 plag:OverThreeYearsMember 2026-09-30 0001117057 plag:FromTwoToThreeYearsMember 2025-12-31 0001117057 plag:FromTwoToThreeYearsMember 2026-09-30 0001117057 plag:FromOneToTwoYearsMember 2025-12-31 0001117057 plag:FromOneToTwoYearsMember 2026-09-30 0001117057 plag:FromSevenToTwelveMonthsMember 2025-12-31 0001117057 plag:FromSevenToTwelveMonthsMember 2026-09-30 0001117057 plag:FromFourToSixMonthsMember 2025-12-31 0001117057 plag:FromFourToSixMonthsMember 2026-09-30 0001117057 plag:LessThan3MonthsMember 2025-12-31 0001117057 plag:LessThan3MonthsMember 2026-09-30 0001117057 2025-01-01 2025-12-31 0001117057 2024-12-31 0001117057 us-gaap:SegmentDiscontinuedOperationsMember 2025-12-31 0001117057 us-gaap:SegmentDiscontinuedOperationsMember 2025-01-01 2025-09-30 0001117057 us-gaap:SegmentDiscontinuedOperationsMember 2026-01-01 2026-09-30 0001117057 plag:JingshanSanheLuckyskyNewEnergyTechnologiesCoLtdMember 2026-06-15 0001117057 plag:BlessChemicalCoLtdMember 2026-06-15 0001117057 plag:ShandongYunchuMember 2025-04-30 0001117057 plag:PromisingProspectHKLimitedMember 2025-04-30 0001117057 plag:AverageHKExchangeRateMember 2025-09-30 0001117057 plag:AverageHKExchangeRateMember 2025-12-31 0001117057 plag:AverageHKExchangeRateMember 2026-09-30 0001117057 plag:AverageRMBExchangeRateMember 2025-09-30 0001117057 plag:AverageRMBExchangeRateMember 2025-12-31 0001117057 plag:AverageRMBExchangeRateMember 2026-09-30 0001117057 plag:AverageCDNExchangeRateMember 2025-09-30 0001117057 plag:AverageCDNExchangeRateMember 2025-12-31 0001117057 plag:AverageCDNExchangeRateMember 2026-09-30 0001117057 plag:HKExchangeRateMember 2025-09-30 0001117057 plag:HKExchangeRateMember 2025-12-31 0001117057 plag:HKExchangeRateMember 2026-09-30 0001117057 plag:RMBExchangeRateMember 2025-09-30 0001117057 plag:RMBExchangeRateMember 2025-12-31 0001117057 plag:RMBExchangeRateMember 2026-09-30 0001117057 plag:CADExchangeRateMember 2025-09-30 0001117057 plag:CADExchangeRateMember 2025-12-31 0001117057 plag:CADExchangeRateMember 2026-09-30 0001117057 us-gaap:TrademarksMember srt:MaximumMember 2026-09-30 0001117057 us-gaap:TrademarksMember srt:MinimumMember 2026-09-30 0001117057 plag:ComputerSoftwareMember srt:MaximumMember 2026-09-30 0001117057 plag:ComputerSoftwareMember srt:MinimumMember 2026-09-30 0001117057 us-gaap:OfficeEquipmentMember srt:MaximumMember 2026-09-30 0001117057 us-gaap:OfficeEquipmentMember srt:MinimumMember 2026-09-30 0001117057 us-gaap:VehiclesMember srt:MaximumMember 2026-09-30 0001117057 us-gaap:VehiclesMember srt:MinimumMember 2026-09-30 0001117057 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2026-09-30 0001117057 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2026-09-30 0001117057 us-gaap:BuildingMember srt:MaximumMember 2026-09-30 0001117057 us-gaap:BuildingMember srt:MinimumMember 2026-09-30 0001117057 srt:MaximumMember 2026-09-30 0001117057 srt:MinimumMember 2026-09-30 0001117057 plag:HubeiKeqibangTechnologyCo.Ltd.ASubsidiaryOfHubeiTaiheBiotechnologyCo.Ltd.Member 2026-01-01 2026-09-30 0001117057 plag:XianningHuaruiTradingCoLtdaSubsidiaryOfXianningBozhuangTeaProductsCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:HubeiTaiheBiotechnologyCoLtdaSubsidiaryOfDingfengTechnologyXianningCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:HubeiLingpuZhengheTechnologyCoLtdaSubsidiaryOfPinnacleTechHKLimitedMember 2026-01-01 2026-09-30 0001117057 plag:PinnacleTechHKLimitedaSubsidiaryOfPromisingProspectBVILimitedMember 2026-01-01 2026-09-30 0001117057 plag:HubeiShengsiliBiotechnologyCoLtdaSubsidiaryOfXianningBozhuangTeaProductsCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:ShineChemicalCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:XianningBozhuangTeaProductsCoLtdaSubsidiaryOfHubeiLingpuZhengheTechnologyCoLtdMember 2026-01-01 2026-09-30 0001117057 plag:ShanghaiShuningAdvertisingCoLtdaSubsidiaryOfFastApproachIncMember 2026-01-01 2026-09-30 0001117057 plag:FastApproachIncMember 2026-01-01 2026-09-30 0001117057 plag:PromisingProspectBVILimitedMember 2026-01-01 2026-09-30 0001117057 2026-09-24 0001117057 plag:HubeiKeqibangTechnologyCo.LtdMember 2026-09-24 0001117057 2025-11-26 0001117057 plag:BozhuangMember 2025-11-26 2025-11-26 0001117057 plag:ShengsiliMember 2025-11-26 0001117057 2024-04-01 2024-04-01 0001117057 plag:AllinysonLtdMember 2022-04-08 0001117057 us-gaap:CommonStockMember 2022-04-08 2022-04-08 0001117057 plag:PromisingHKShandongYunchuAndJiayiTechnologiesMember 2025-09-01 2025-09-01 0001117057 plag:ShandongYunchuMember 2025-09-01 0001117057 plag:PromisingHKMember 2025-09-01 2025-09-01 0001117057 plag:ShandongYunchuSupplyChainCoLtdMember 2021-12-09 0001117057 2021-12-09 2021-12-09 0001117057 2021-01-06 2021-01-06 0001117057 plag:JingshanSanheMember 2026-06-15 0001117057 plag:VIEAgreementsMember plag:JingshanSanheLuckyskyNewEnergyTechnologiesCoLtdMember 2026-06-15 0001117057 plag:HubeiBulaisiMember 2022-09-14 0001117057 2022-09-14 2022-09-14 0001117057 plag:HubeiBryceTechnologyCoLtdMember plag:JingshanMember 2022-09-14 2022-09-14 0001117057 plag:JingshanMember 2022-09-14 0001117057 plag:JiayiTechnologiesXianningCoLtdMember 2021-01-06 0001117057 plag:JiayiTechnologiesXianningCoLtdMember 2021-01-06 2021-01-06 0001117057 plag:LuckySkyPetrochemicalToLuckySkyPlanetGreenHoldingsCoLimitedHKMember 2020-06-16 0001117057 plag:XianningBozhuangTeaProductsCoLtdMember 2021-08-01 0001117057 plag:BoZhuangShareholdersMember 2019-05-09 2019-05-09 0001117057 2025-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2026-09-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001117057 us-gaap:RetainedEarningsMember 2026-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001117057 us-gaap:CommonStockMember 2026-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-09-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-09-30 0001117057 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2025-12-31 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001117057 us-gaap:RetainedEarningsMember 2025-12-31 0001117057 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001117057 us-gaap:CommonStockMember 2025-12-31 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001117057 us-gaap:RetainedEarningsMember 2025-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001117057 us-gaap:CommonStockMember 2025-09-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001117057 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001117057 us-gaap:RetainedEarningsMember 2024-12-31 0001117057 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001117057 us-gaap:CommonStockMember 2024-12-31 0001117057 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001117057 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001117057 2026-06-30 0001117057 us-gaap:NoncontrollingInterestMember 2026-06-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001117057 us-gaap:RetainedEarningsMember 2026-06-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001117057 us-gaap:CommonStockMember 2026-06-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001117057 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001117057 2025-06-30 0001117057 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001117057 us-gaap:RetainedEarningsMember 2025-06-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001117057 us-gaap:CommonStockMember 2025-06-30 0001117057 2026-11-13 0001117057 us-gaap:NoncontrollingInterestMember 2025-06-30 0001117057 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2025-09-30 0001117057 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2024-12-31 0001117057 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001117057 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001117057 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0001117057 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember plag:CustomersEMember 2025-01-01 2025-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersFMember 2025-01-01 2025-09-30 0001117057 plag:ChajiaduoSupplyChainHubeiCoLtdMember 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomersAMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomersBMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomerCMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001117057 us-gaap:CustomerConcentrationRiskMember plag:CustomerDMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersAMember 2026-01-01 2026-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersBMember 2025-01-01 2025-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersCMember 2025-01-01 2025-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersDMember 2025-01-01 2025-09-30 0001117057 us-gaap:SupplierConcentrationRiskMember plag:PurchaseBenchmarkMember plag:SuppliersEMember 2025-01-01 2025-09-30 0001117057 plag:HubeiKeqibangMember 2025-12-31 0001117057 plag:MsLuojiePuMember 2026-09-30 0001117057 plag:MsYeZhangMember 2026-09-30 0001117057 plag:MrYangYongMember 2025-12-31 0001117057 plag:AmericanOrCanandaMember 2026-09-30 0001117057 plag:AmericanOrCanandaMember 2025-12-31 0001117057 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares iso4217:CNY xbrli:pure plag:Segments

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ____________

 

Commission File Number: 001-34449

 

PLANET GREEN HOLDINGS CORP.
(Exact name of registrant as specified in its charter)

 

Nevada   87-0430320
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification Number)

 

130-30 31st Ave, Suite 512
Flushing, NY 11354

(Address of principal executive office and zip code)

 

(347) 370-2352
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   PLAG   NYSE American

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of outstanding shares of the registrant’s common stock as of November 13, 2026 was 14,266,722.

 

 

 

 

 

TABLE OF CONTENT

 

    PAGE
     
PART I - FINANCIAL INFORMATION 1
     
ITEM 1 FINANCIAL STATEMENTS 2
     
ITEM 2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 27
     
ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 31
     
ITEM 4 CONTROLS AND PROCEDURES 31
     
PART II - OTHER INFORMATION 32
     
ITEM 1 LEGAL PROCEEDINGS 32
   
ITEM 1A RISK FACTORS 32
     
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 32
     
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 32
     
ITEM 4 MINE SAFETY DISCLOSURES 32
     
ITEM 5 OTHER INFORMATION 32
     
ITEM 6 EXHIBITS 33
     
SIGNATURES 34

 

i

 

Caution Regarding Forward-Looking Statements

 

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to the factors described in the section captioned “Risk Factors” in the Registration Statement on Form S-3/A filed by the Company on April 2, 2026, and as subsequently amended, together with the other information contained in this report. If any of the events described in the risk factors occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.

 

In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” or the negative of such terms or other similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our estimates and assumptions only as of the date of this report. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect.

 

Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

 

ii

 

PART I

 

Use of Certain Defined Terms

 

Except where the context otherwise requires and for the purposes of this report only: 

 

  ● “Allinyson” refers to Allinyson Ltd., a company incorporated in the State of Colorado.
     
  ● “Bless Chemical” refers to Bless Chemical Co., Ltd., a company incorporated in Hong Kong.
     
  ● “Bozhuang” refers to Xianning Bozhuang Tea Products Co., Ltd., a PRC limited liability company.
     
  ● “China” and “PRC” refer to the People’s Republic of China including Hong Kong and Macau.

 

  ● “Hubei Lingpu” refers to Hubei Lingpu Zhenghe Technology Co., Ltd. (formerly Dingfeng Biotechnology Xianning Co., Ltd.), a PRC limited liability company and a wholly foreign-owned enterprise. The entity changed its name to Hubei Lingpu Zhenghe Technology Co., Ltd. on April 29, 2026.
     
  ● “Fast Approach” refers to Fast Approach Inc., a corporation incorporated under the laws of Canada.
     
  ● “Hubei Bulaisi” refers to Hubei Bulaisi Technology Co., Ltd., a PRC limited liability company.

 

  ● “Hubei Shengsili” refers to Hubei Shengsili Biotechnology Co., Ltd., a PRC limited liability company.
     
  ● “Hubei Taihe” refers to Hubei Taihe Biotechnology Co., Ltd., a PRC limited liability company.
     
  ● “Jiayi Technologies” refers to Jiayi Technologies (Xianning) Co., Ltd., a PRC limited liability company.

 

  ● “Jingshan Sanhe” refers to Jingshan Sanhe Luckysky New Energy Technologies Co., Ltd., a PRC limited liability company.
     
  ● “PinnacleTech HK” refers to PinnacleTech HK Limited, a company incorporated in Hong Kong

 

  ● “Promising HK” refers to Promising Prospect HK Limited, a company incorporated in Hong Kong.

 

  ● “Planet Green” refers to Planet Green Holdings Corp., a Nevada holding company.
     
  ● “Promising Prospect BVI” refers to Promising Prospect Limited, formerly known as Planet Green Holdings Corporation, a British Virgin Islands company.

 

  ● “RMB” refers to Renminbi, the legal currency of China.

 

  ● “Shanghai Shuning” refers to Shanghai Shuning Advertising Co., Ltd., a PRC limited liability company.

 

  ● “U.S. dollar”, “$” and “US$” refer to the legal currency of the United States.

 

  ● “We,” “us”, “our,” “PLAG”, and the “Company” refer to Planet Green Holdings Corp., a Nevada corporation, and, except where the context requires otherwise, our wholly-owned subsidiaries and VIE.

 

  ● “Shine Chemical” refers to Shine Chemical Co., Ltd., a company incorporated in Cayman Islands.

 

1

 

ITEM 1 FINANCIAL STATEMENTS

 

Planet Green Holdings Corp.

Condensed Consolidated Balance Sheets

 

    September 30,     December 31,  
    2026     2025  
    (Unaudited)        
Assets            
Current assets            
Cash   $ 356,476     $ 15,751  
Accounts receivable, net     250,011       134,330  
Inventories, net     482,933       599,264  
Advances to suppliers, net     122,079       37,619  
Other receivables, net     1,521,319       1,038  
Other receivables-related parties     -       6,385  
Prepaid expenses     22       21  
Assets of discontinued operations     -       7,080,393  
Total current assets     2,732,840       7,874,801  
                 
Non-current assets                
Plant and equipment, net     2,619,795       2,719,417  
Intangible assets, net     696,269       709,243  
Construction in progress, net     -       23,909  
Right-of-use lease assets, net     78,948       -  
Goodwill     27,142       7,005  
Total non-current assets     3,422,154       3,459,574  
                 
Total assets   $ 6,154,994     $ 11,334,375  
                 
Liabilities and Stockholders’ Equity                
Current liabilities                
Short-term bank loans   $ 5,446     $ 72,284  
Current portion of long-term bank loans     -       71,499  
Accounts payable     2,114,673       723,867  
Advance from customers     324,674       150,927  
Taxes payable     290,461       135,911  
Other payables     2,048,965       1,810,202  
Accrued liabilities     909,128       802,636  
Other payables-related parties     3,448,165       2,948,824  
Operating lease liability, current     48,764       -  
Liabilities of discontinued operations     -       6,788,268  
Total current liabilities     9,190,276       13,504,418  
                 
Non-current liabilities                
Operating lease liability, noncurrent     27,031       -  
Total non-current liabilities     27,031       -  
                 
Total liabilities     9,217,307       13,504,418  
                 
Commitments and contingencies                
                 
Stockholders’ deficit                
Preferred stock: $0.001 par value, 100,000,000 shares authorized; none issued or outstanding as of September 30, 2026 and December 31, 2025     -       -  
Common stock: $0.001 par value, 1,500,000,000 shares authorized; 14,232,714 shares issued and outstanding as of September 30, 2026 and December 31, 2025     14,233       14,233  
Additional paid-in capital     170,190,324       170,190,324  
Accumulated deficit     (176,077,537 )     (175,029,363 )
Accumulated other comprehensive income     2,803,797       2,658,143  
Non-controlling interests     6,870       (3,380 )
Total stockholders’ deficit     (3,062,313 )     (2,170,043 )
                 
Total liabilities and stockholders’ deficit   $ 6,154,994     $ 11,334,375  

 

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

 

2

 

Planet Green Holdings Corp.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Net revenues   $ 2,493,318     $ 3,604     $ 9,583,897     $ 67,270  
Cost of revenues     (2,412,466 )     (1,761 )     (3,531,444 )     (9,724 )
Promotion cost     -       -       (5,145,354 )     -  
Gross profit     80,852       1,843       907,099       57,546  
                                 
Operating expenses:                                
Selling and marketing expenses     3,908       3,392       14,610       11,407  
General and administrative expenses     424,643       3,067,181       1,508,853       3,765,191  
Research and development expenses     115       -       1,069       -  
Total operating expenses     428,666       3,070,573       1,524,532       3,776,598  
                                 
Operating loss     (347,814 )     (3,068,730 )     (617,433 )     (3,719,052 )
                                 
Other (expenses) income                                
Interest income     34       -       376       2  
Interest expenses     (295 )     (3,916 )     (1,031 )     (8,180 )
Other income     1,041       -       1,041       -  
Other expenses     (19,903 )     (28 )     (20,489 )     (6,020 )
Total other expenses     (19,123 )     (3,944 )     (20,103 )     (14,198 )
                                 
Loss before income taxes     (366,937 )     (3,072,674 )     (637,536 )     (3,733,250 )
                                 
Income tax expenses     (374 )     (11,290 )     (9,150 )     (11,290 )
                                 
Loss from continuing operations     (367,311 )     (3,083,964 )     (646,686 )     (3,744,540 )
                                 
Discontinued operations:                                
Loss from discontinued operations     (24,348 )     (9,064,329 )     (391,269 )     (9,974,236 )
                                 
Net loss     (391,659 )     (12,148,293 )     (1,037,955 )     (13,718,776 )
                                 
Less: Net income attributable to non-controlling interest     62,282       -       10,219       -  
                                 
Net loss attributable to ordinary shareholders of Planet Green Holdings Corp.     (453,941 )     (12,148,293 )     (1,048,174 )     (13,718,776 )
                                 
Net loss     (391,659 )     (12,148,293 )     (1,037,955 )     (13,718,776 )
Foreign currency translation adjustment     34,393       (37,907 )     145,685       (91,244 )
Total comprehensive loss     (357,266 )     (12,186,200 )     (892,270 )     (13,810,020 )
Less: comprehensive loss attributable to non-controlling interests     63,010       -        10,250       -  
Comprehensive loss attributable to shareholders of Planet Green Holdings Corp.     (420,276 )     (12,186,200 )     (902,520 )     (13,810,020 )
                                 
Loss per common share - basic and diluted                                
Continuing operations   $ (0.03 )   $ (0.42 )   $ (0.05 )   $ (0.51 )
Discontinuing operations   $ (0.00 )   $ (1.24 )   $ (0.03 )   $ (1.37 )
                                 
Basic and diluted weighted average shares outstanding     14,232,714       7,282,714       14,232,714       7,282,714  

 

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

 

3

 

Planet Green Holdings Corp.

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

For the Three Months Ended September 30, 2026 and 2025

 

                            Accumulated              
                Additional           Other     Non-     Total  
    Common Stock     Paid-in     Accumulated     Comprehensive     Controlling     Equity  
    Shares     Amount     Capital     Deficit     Income     Interests     (Deficit)  
Balance as of July 1, 2025     7,282,714     $ 7,283     $ 155,767,774     $ (149,624,136 )   $ 3,919,121     $                -     $ 10,070,042  
Net loss     -       -       -       (12,148,293 )     -       -       (12,148,293 )
Disposal of subsidiaries     -       -       -       -       (1,255,870 )     -       (1,255,870 )
Stock based compensation     -       -       2,798,500       -       -       -       2,798,500  
Foreign currency translation adjustment     -       -       -       -       (37,907 )     -       (37,907 )
Balance as of September 30, 2025     7,282,714     $ 7,283     $ 158,566,274     $ (161,772,429 )   $ 2,625,344     $ -     $ (573,528 )

 

                            Accumulated              
                Additional           Other     Non-     Total  
    Common Stock     Paid-in     Accumulated     Comprehensive     Controlling     Equity  
    Shares     Amount     Capital     Deficit     Income     Interests     (Deficit)  
Balance as of July 1, 2026     14,232,714     $ 14,233     $ 170,190,324     $ (175,623,596 )   $ 2,770,132     $ (56,140 )   $ (2,705,047 )
Net (loss) income     -       -       -       (453,941 )     -       62,282       (391,659 )
Foreign currency translation adjustment     -       -       -       -       33,665       728       34,393  
Balance as of September 30, 2026     14,232,714     $ 14,233     $ 170,190,324     $ (176,077,537 )   $ 2,803,797     $ 6,870     $ (3,062,313 )

 

4

 

Planet Green Holdings Corp.

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

For the Nine Months Ended September 30, 2026 and 2025

 

                            Accumulated              
                Additional           Other     Non-     Total  
    Common Stock     Paid-in     Accumulated     Comprehensive     Controlling     Equity  
    Shares     Amount     Capital     Deficit     Income     Interests     (Deficit)  
Balance as of January 1, 2025     7,282,714     $ 7,283     $ 155,767,774     $ (148,053,653 )   $ 3,972,458     $                  -     $ 11,693,862  
Net loss     -       -       -       (13,718,776 )     -       -       (13,718,776 )
Disposal of subsidiaries     -       -       -       -       (1,255,870 )     -       (1,255,870 )
Stock based compensation     -       -       2,798,500       -       -       -       2,798,500  
Foreign currency translation adjustment     -       -       -       -       (91,244 )     -       (91,244 )
Balance as of September 30, 2025     7,282,714     $ 7,283     $ 158,566,274     $ (161,772,429 )   $ 2,625,344     $ -     $ (573,528 )

 

                            Accumulated              
                Additional           Other     Non-     Total  
    Common Stock     Paid-in     Accumulated     Comprehensive     Controlling     Equity  
    Shares     Amount     Capital     Deficit     Income     Interests     (Deficit)  
Balance as of January 1, 2026     14,232,714     $ 14,233     $ 170,190,324     $ (175,029,363 )   $ 2,658,143     $ (3,380 )   $ (2,170,043 )
Net (loss) income     -       -       -       (1,048,174 )     -       10,219       (1,037,955 )
Acquiring subsidiaries     -       -       -       -       -       (2,720 )     (2,720 )
Disposal of subsidiaries     -       -       -       -       -       2,720       2,720  
Foreign currency translation adjustment     -       -       -       -       145,654       31       145,685  
Balance as of September 30, 2026     14,232,714     $ 14,233     $ 170,190,324     $ (176,077,537 )   $ 2,803,797     $ 6,870     $ (3,062,313 )

 

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

 

5

 

Planet Green Holdings Corp.

Unaudited Condensed Consolidated Statements of Cash Flows

 

    For the Nine Months Ended
September 30,
 
    2026     2025  
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss   $ (1,037,955 )   $ (13,718,776 )
Add: net loss from discontinued operations     391,269       9,974,236  
Net loss from continuing operations     (646,686 )     (3,744,540 )
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:                
Depreciation     318,323       231,466  
Amortization     42,762       99,396  
Amortization of operating lease right-of-use assets     18,452       -  
Allowance for doubtful accounts     77,408       32,651  
Stock based compensation     -       2,798,500  
Loss on disposal of plant and equipment     2       -  
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:                
Accounts receivables     (182,919 )     8,488  
Inventories     139,701       7,629  
Advances to suppliers     (83,433 )     90,508  
Other receivables     (1,496,871 )     1,696  
Accounts payable     1,337,400       (6,907 )
Advance from customer     168,015       (26,377 )
Other payables     209,767       (29,232 )
Accrued liabilities     102,476       140,376  
Taxes payable     146,469       41,440  
Operating lease liabilities     (21,550 )     -  
Net cash provided by (used in) operating activities from continuing operations     129,316       (354,906 )
Net cash used in operating activities from discontinued operations     (504,701 )     (970,601 )
Net cash used in operating activities     (375,385 )     (1,325,507 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Purchase of plant and equipment     (82,124 )     -  
Acquisition of subsidiaries     (19,499 )     -  
Cash received from disposal of plant and equipment     440       -  
Net cash used in investing activities from continuing operations     (101,183 )     -  
Net cash provided by (used in) investing activities from discontinued operations     325       (2,474 )
Net cash used in investing activities     (100,858 )     (2,474 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from bank loans     4,810       -  
Repayment of bank loans     (146,608 )     (215 )
Proceeds from related parties     449,076       323,740  
Net cash provided by financing activities from continuing operations     307,278       323,525  
Net cash provided by financing activities from discontinued operations     504,376       876,006  
Net cash provided by financing activities     811,654       1,199,531  
                 
Net increase (decrease) in cash     335,411       (128,450 )
                 
Effect of changes of foreign exchange rates on cash     5,314       98,243  
                 
Cash at beginning of period     15,751       48,415  
                 
Cash at end of period   $ 356,476     $ 18,208  
                 
SUPPLEMENTARY OF CASH FLOW INFORMATION                
Interest received   $ 376     $ 2  
Interest paid   $ 1,031     $ 8,180  

 

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

 

6

 

PLANET GREEN HOLDINGS CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

1. Organization and Principal Activities

 

Planet Green Holdings Corp. (the “Company” or “PLAG”) is a holding company incorporated in Nevada. We are engaged in various businesses through our subsidiaries in China and Canada.

  

On May 9, 2019, the Company issued an aggregate of 1,080,000 shares of Planet Green Holdings Corporation’s common stock to the BoZhuang Shareholders, in exchange for BoZhuang Shareholders’ agreement to enter into VIE Agreements (the “BoZhuang VIE Agreements”). On August 1, 2021, the VIE agreements with Xianning Bozhuang Tea Products Co., Ltd. was terminated and the company acquired 100% equity of Xianning Bozhuang Tea Products Co., Ltd. for restructuring purposes.

 

On August 12, 2019, through Lucky Sky HK, the Company established Lucky Sky Petrochemical, a wholly foreign-owned enterprise incorporated in Xianning City, Hubei Province, China. On December 9, 2020, Lucky Sky Petrochemical Technology (Xianning) Co., Ltd. changed its name to Jiayi Technologies (Xianning) Co., Ltd. (“Jiayi Technologies”)

 

On May 29, 2020, Promising Prospect BVI Limited incorporated Lucky Sky Planet Green Holdings Co., Limited, a limited liability company incorporated in Hong Kong.

 

On June 5, 2020, Promising Prospect BVI Limited acquired all of the outstanding equity interests of Fast Approach Inc. Fast Approach was incorporated under Canada’s laws and provides digital advertising delivery and operational services, with China and North America serving as its two core markets. 

 

On June 16, 2020, Lucky Sky Holdings Corporations (H.K.) transferred its 100% equity interest in Lucky Sky Petrochemical to Lucky Sky Planet Green Holdings Co., Limited (H.K.).

 

On January 6, 2021, Planet Green Holdings Corporation (Nevada) issued an aggregate of 2,200,000 shares of common stock of the Company to the equity holders of Jingshan Sanhe Luckysky New Energy Technologies Co., Ltd. (“Jingshan Sanhe”) in exchange for the transfer of 85% of the equity interest of Jingshan Sanhe Luckysky New Energy Technologies Co., Ltd to the Jiayi Technologies (Xianning) Co., Ltd. For restructuring purposes, on September 1, 2021, the VIE agreements with Jingshan Sanhe were terminated and Hubei Bulaisi Technology Co., Ltd. (“Hubei Bulaisi”) acquired the shares of Jingshan Sanhe. On September 14, 2022, Planet Green Holdings Corp. and Hubei Bulaisi a subsidiary of the Company, entered into a Share Purchase Agreement with Xue Wang, a shareholder of Jingshan Sanhe, pursuant to which, among other things and subject to the terms and conditions contained therein, the Purchaser agreed to effect share purchase from the Seller of 15% of the outstanding equity interests of Jingshan, and the Company shall pay to the Seller an aggregate of U.S. $3,000,000 in exchange for 15% of the issued and outstanding shares. On September 14, 2022, the Company closed the Share Purchase transaction. As a result, Hubei Bulaisi owned 100% shares of Jingshan Sanhe. On June 15, 2026, the Company completed disposition of its 100% equity interest in Bless Chemical Co., Ltd. (“Bless Chemical”) for nominal consideration. Bless Chemical held the 100% equity interest in Jingshan Sanhe. through Hubei Bulaisi and did not own any other operating assets of the Company. The disposal of Bless Chemical, Hubei Bulaisi and Jingshan Sanhe resulted in gain from disposal of $235,815.

 

On December 9, 2021, Planet Green Holdings Corporation (Nevada) issued an aggregate of 5,900,000 shares of common stock to the equity holders of Shandong Yunchu Supply Chain Co., Ltd. (“Shandong Yunchu”) for the transfer to 100% of the equity interest of Shandong Yunchu to the Jiayi Technologies (Xianning) Co., Ltd. For the best interest of the Company, on April 30, 2025, the Board resolved to discontinue the operation of Shandong Yunchu. Subsequently, on September 1, 2025, the Company disposed of its 100% equity interest in Promising Prospect HK Limited (“Promising HK”) for nominal consideration. Promising HK holds the 100% equity interest in Shandong Yunchu through Jiayi Technologies and does not own any other operating assets of the Company. The disposal of Promising HK, Shandong Yunchu and Jiayi Technologies resulted in loss from disposal of approximately $9.2 million.

 

7

 

On April 8, 2022, Planet Green Holdings Corporation (Nevada) issued an aggregate of 7,500,000 shares of common stock to the equity holders of Allinyson Ltd. for the acquisition of 100% of the equity interest of Allinyson Ltd., including its wholly-owned subsidiary Baokuan Technology (Hongkong) Limited. On April 1, 2024, Allinyson Ltd. and its subsidiaries have been completely disposed, resulting in gain from disposal of $355,517.

 

On November 26, 2025, Bozhuang entered into a Share Purchase Agreements with shareholders of Hubei Shengsili Biotechnology Co., Ltd. (“Hubei Shengsili”), to acquire 67% equity interests in Hubei Shengsili for a consideration of $145, resulting in goodwill of $7,101. The nominal consideration reflects the strategic nature of the acquisition, as the Company acquired Hubei Shengsili primarily for its operational platform and distribution network in the biotechnology sector, rather than for its existing net asset value.

 

On December 16, 2025, the Company incorporated PinnacleTech HK Limited (“PinnacleTech HK”), a limited liability company incorporated in Hong Kong.

 

On December 24, 2025, through PinnacleTech HK, the Company incorporated Hubei Lingpu Zhenghe Technology Co., Ltd. (“Hubei Lingpu”) in Xianning City, Hubei Province, China. Hubei Lingpu is a wholly foreign-owned enterprise, formerly known as Dingfeng Biotechnology Xiangning Co., Ltd. prior to its name change on April 29, 2026.

 

On March 10, 2026, the Company incorporated Hubei Taihe Biotechnology Co., Ltd. (“Hubei Taihe”), a PRC limited liability company.

 

On March 24, 2026, the Company incorporated Xianning Huarui Trading Co., Ltd. (“Xianning Huarui”), a PRC limited liability company.

 

On September 24, 2026, Hubei Taihe entered into a Share Purchase Agreements with shareholders of Hubei Keqibang Technology Co., Ltd. (“Hubei Keqibang”), to acquire 100% equity interests in Hubei Keqibang for a consideration of $19,836, resulting in goodwill of $19,836.

 

Liquidity and Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern; however, the Company has incurred a net loss from continuing operations of $646,686 for the nine months ended September 30, 2026, and it’s the net cash provided by operating activities from continuing operations for the nine months ended September 30, 2026 was $129,316. As of September 30, 2026, the Company had an accumulated deficit of $176,077,537, and a working capital deficit of $6,457,436.

 

These factors raise substantial doubt on the Company’s ability to continue as a going concern. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company has recently expanded its sales and marketing efforts by engaging sales agents to promote its tea products and enhance market penetration. The Company believes this sales agent model enables it to improve its profit and cash flow. Management’s plan for the Company’s continued existence is dependent upon management’s ability to execute the business plan and generate additional profit. Additionally, Management may need to continue to rely on private placements or other financing transactions or certain related parties to provide funding for investment, for working capital and general corporate purposes. If management is unable to execute its plan, the Company may become insolvent.

 

8

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and the notes thereto for the year ended December 31, 2025 included in the Form 10-K filed on March 31, 2026. Operating results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. All inter-company balances and transactions are eliminated upon consolidation.

 

Segment Reporting

 

The Company operates as a single operating and reportable segment in accordance with ASC 280 Segment Reporting. The Company’s operating segments are determined based on the financial information regularly reviewed by the chief operating decision maker (“CODM”) for purposes of assessing operating performance and allocating resources. The Company’s CODM is its Chief Executive Officer, who reviews the Company’s financial performance on a consolidated basis. The CODM primarily uses consolidated net income (loss) to evaluate operating performance, allocate resources, and make strategic and operational decisions.

 

The Company’s single reportable segment comprises its consolidated operations. Accordingly, the segment’s revenue and net income (loss) are consistent with the corresponding amounts reported in the unaudited condensed consolidated statements of operations. Because substantially all of the Company’s long-lived assets and revenues are located in and derived from China, the Company does not distinguish between markets for the purpose of internal reporting, and therefore, geographical segments are not presented. Significant segment expenses and other segment items for the three and nine months ended September 30, 2026 and 2025 are presented below.

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Net revenues   $ 2,493,318     $ 3,604     $ 9,583,897     $ 67,270  
Cost of revenues     (2,412,466 )     (1,761 )     (3,531,444 )     (9,724 )
Promotion cost     -       -       (5,145,354 )     -  
Segment gross profit     80,852       1,843       907,099       57,546  

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Segment gross profit     80,852       1,843       907,099       57,546  
Less:                                
Selling and marketing expenses     3,908       3,392       14,610       11,407  
General and administrative expenses     424,643       3,067,181       1,508,853       3,765,191  
Research and development expenses     115       -       1,069       -  
Add (less):                                
Interest income     34       -       376       2  
Interest expenses     (295 )     (3,916 )     (1,031 )     (8,180 )
Other income     1,041       -       1,041       -  
Other expenses     (19,903 )     (28 )     (20,489 )     (6,020 )
Loss before income taxes     (366,937 )     (3,072,674 )     (637,536 )     (3,733,250 )

 

9

 

Principles of Consolidation

 

Details of the Subsidiaries of the Company as of September 30, 2026 are set below:

 

Name of Company   Place of
incorporation
  Attributable
equity
interest %
 
Promising Prospect BVI Limited   The British Virgin Islands     100  
Fast Approach Inc.   Canada     100  
Shanghai Shuning Advertising Co., Ltd. (a subsidiary of Fast Approach Inc.)   PRC     100  
Xianning Bozhuang Tea Products Co., Ltd. (a subsidiary of Hubei Lingpu Zhenghe Technology Co., Ltd.)   PRC     100  
Shine Chemical Co., Ltd.   Cayman     100  
Hubei Shengsili Biotechnology Co., Ltd. (a subsidiary of Xianning Bozhuang Tea Products Co., Ltd.)   PRC     67  
PinnacleTech HK Limited (a subsidiary of Promising Prospect BVI Limited)   Hong Kong     100  
Hubei Lingpu Zhenghe Technology Co., Ltd. (a subsidiary of PinnacleTech HK Limited)   PRC     100  
Hubei Taihe Biotechnology Co., Ltd. (a subsidiary of Hubei Lingpu Zhenghe Technology Co., Ltd.)   PRC     100  
Xianning Huarui Trading Co., Ltd. (a subsidiary of Xianning Bozhuang Tea Products Co., Ltd.)   PRC     100  
Hubei Keqibang Technology Co., Ltd. (a subsidiary of Hubei Taihe Biotechnology Co., Ltd.)   PRC     100  

 

Management has eliminated all significant inter-company balances and transactions in preparing the accompanying unaudited condensed consolidated financial statements.

  

Reclassifications

 

Certain amounts on the prior years’ consolidated balance sheets and statement of operations were reclassified to reflect discontinued operations, with no effect on ending stockholders’ equity. Salaries payable on the prior years’ consolidated balance sheets was reclassified from accounts payable to accrued liabilities.

 

Use of Estimates

 

The unaudited condensed consolidated financial statements preparation requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Management evaluates estimates, including the allowance for credit losses of accounts receivable, amounts due from related parties and equity investments, the useful lives of our property and equipment, impairment of long-lived assets, long-term investments and goodwill, etc. Management bases the estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.  

 

Cash

 

Cash includes currency on hand and deposits held by banks that can be added or withdrawn without limitation. The Company maintains most of its bank accounts in the PRC. Cash maintained in banks within the People’s Republic of China of less than RMB0.5 million (equivalent to $74,577) per bank are covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China.

 

10

 

Accounts Receivable, Net

 

Accounts receivables are recognized and carried at the original invoice amount less allowance for any uncollectible amounts. An estimate for doubtful accounts is made when the amount is not expected to be collected. Delinquent amount balances are written off against the allowance for doubtful amounts after the management has determined that the likelihood of collection is not probable.

 

Inventories, Net

 

Inventories consist of raw materials and finished goods, stated at the lower of cost or market value. Finished goods are comprised of direct materials, direct labor, inbound shipping costs, and allocated overhead. An annual impairment test will be performed on inventory, and any excess of the recoverable amount over the carrying amount will be recognized as impairment losses in the current period.

 

Advances to Suppliers, Net

 

The Company makes advance payments to suppliers and vendors for the procurement of raw materials. Upon physical receipt and inspection of the raw materials from suppliers, the applicable amount is reclassified from advances and prepayments to suppliers to inventory. The Company reviews its advance to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier to provide supplies to the Company or refund an advance. 

 

Plant and Equipment

 

Plant and equipment are carried at cost less accumulated depreciation. Depreciation is provided over their estimated useful lives, using the straight-line method. The Company typically applies a salvage value of 0% to 5%. The estimated useful lives of the plant and equipment are as follows:

 

Buildings   3-30 years
Machinery and equipment   3-10 years
Motor vehicles   4-10 years
Office equipment   1-10 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts, and any gain or loss is included in the Company’s results of operations. The costs of maintenance and repairs are recognized as incurred; significant renewals and betterments are capitalized.

  

Intangible Assets

 

Intangible assets are carried at cost less accumulated amortization. Amortization is provided over their useful lives, using the straight-line method. The estimated useful lives of the intangible assets are as follows: 

 

Land use rights   50 years
Software licenses   2-5 years
Trademarks   7-16 years

 

11

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. The Company conducts an annual assessment of its goodwill for impairment. If the carrying value of its goodwill exceeds its fair value, then impairment has been incurred; accordingly, a charge to the Company’s operations results will be recognized during the period. Impairment losses on goodwill are not reversed. Fair value is generally determined using a discounted expected future cash flow analysis.

 

Impairment of Long-lived Assets

 

The Company annually reviews its long-lived assets for impairment or whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Impairment may become obsolete from a difference in the industry, introduction of new technologies, or if the Company has inadequate working capital to utilize the long-lived assets to generate adequate profits. Impairment is present if the carrying amount of an asset is less than its expected future undiscounted cash flows.

 

If an asset is considered impaired, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the asset. Assets to be disposed of are reported lower the carrying amount or fair value fewer costs to selling.

 

Statutory Reserves

 

Statutory reserves refer to the amount appropriated from the net income following laws or regulations, which can be used to recover losses and increase capital, as approved, and are to be used to expand production or operations. PRC laws prescribe that an enterprise operating at a profit must appropriate and reserve, on an annual basis, an amount equal to 10% of its profit. Such an appropriation is necessary until the reserve reaches a maximum equal to 50% of the enterprise’s PRC registered capital.

 

Foreign Currency Translation

 

The accompanying unaudited condensed consolidated financial statements are presented in United States dollars. The Company’s assets and liabilities are translated into United States dollars from RMB at period-end exchange rates. Its revenues and expenses are translated at the average exchange rate during the period. Capital accounts are translated at their historical exchange rates when the capital transactions occurred.

 

    September 30,
2026
    December 31,
2025
    September 30,
2025
 
Period-end US$: CDN exchange rate     1.4210       1.3712       1.3927  
Period-end US$: RMB exchange rate     6.7045       6.9931       7.1190  
Period-end US$: HK exchange rate     7.8467       7.7833       7.7809  
Period average US$: CDN exchange rate     1.3850       1.3973       1.3984  
Period average US$: RMB exchange rate     6.8209       7.1875       7.2201  
Period average US$: HK exchange rate     7.8304       7.7956       7.8015  

 

The RMB is not freely convertible into foreign currencies, and all foreign exchange transactions must be conducted through authorized financial institutions.

 

12

 

Revenue Recognition

 

The Company adopted ASC 606 “Revenue Recognition.” It recognizes revenue when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

 

The Company derives its revenues from manufacture and distribution of tea products, and providing online advertising services. The Company recognizes product revenue at a point in time when the control of the products or services has been transferred to customers. The Company applies the following five steps to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;

 

  ● identify the performance obligations in the contract;

 

  ● determine the transaction price;

 

  ● allocate the transaction price to performance obligations in the contract; and;

 

  ● Recognize revenue as the performance obligation is satisfied.

 

(a) Tea products

 

The Company entered sales contracts with various companies and/or individuals. Pursuant to sales contracts entered, the Company is to provide the required tea products to its customers without a right of return. The Company shall deliver the ordered tea products within seven days after receiving of purchase order, and the delivery expense is borne by the customers. The customer shall inspect the quantity and quality of the products received timely and notify any noncompliance to the Company on the day of receipt, and no return will be grant after customers’ acceptances.

 

The Company recognizes revenue when it transfers its goods to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. The Company accounts for revenue generated from sales of its tea products on a gross basis, as the Company is acting as a principal in these transactions, is subject to inventory risk, has latitude in establishing prices, and is responsible for fulfilling the promise to provide customers the specified goods, which the Company has control of the goods and has the ability to direct the use of goods to obtain substantially all the benefits. All of the Company’s contracts have one single performance obligation, namely, the promise is to transfer the individual goods to customers, and there is no separately identifiable other promise in the contracts. There are no material concerns about the Company's ability to collect payment as most of its customers are long-term cooperative clients.

 

The Company’s revenue is recognized at a point in time when title and risk of loss passes and customers inspect and accept the goods, which generally occurs at day of delivery.

 

(b) Online advertising services

 

The Company entered service contracts with various companies to provide online advertising services, including advertising platform recharge service, advertising shooting service and advertisement putting service. Contract price is fixed for each customer and are collected in advance and initially recorded as contract liabilities. There is one single performance obligation, namely, the promise is to deliver the advertising service to customers, and no separately identifiable other promise in the contracts. Customers have no right of return after service is delivered. Revenue is recognized when the Company delivers its service to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange.

 

13

 

The Company accounts for revenue generated from online advertising services on a gross basis, as the Company is acting as a principal in these transactions. The Company identifies appropriate advertising platforms based on customer requirements, offer differential pricing to varies customers, has control of the service and primary responsibility for service quality, advertising effectiveness, compliance, missed or incorrect broadcasts, customer complaints and assumes fulfillment risk.

 

The Company’s revenue is recognized at a point in time when customers inspect and accept the services, which generally occurs at day of delivery.

 

Cost of revenue

 

Cost of revenue consists primarily of the costs of finished goods manufactured and procurement cost of packaging, freight charges, depreciation of property and machinery and warehousing expenses. Cost of revenue also includes incremental costs of obtaining sales contract, which are mainly promotion cost paid to distributors in the amount in-line with sales revenue realized.

 

Advertising

 

All advertising costs are expensed as incurred.

 

Shipping and Handling

 

All outbound shipping and handling costs are expensed as incurred.

 

Research and Development

 

All research and development costs are expensed as incurred.

 

Retirement Benefits

 

Retirement benefits in the form of mandatory government-sponsored defined contribution plans are charged to either expense as incurred or allocated to inventory as part of overhead.

 

Income Taxes

 

The Company accounts for income tax using an asset and liability approach and recognizes deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not, these items will either expire before the Company can realize their benefits or uncertain future realization.

 

Comprehensive Income

 

The Company uses Financial Accounting Standards Board (“FASB”) ASC Topic 220, “Reporting Comprehensive Income.” Comprehensive income is comprised of net income and all changes to the statements of stockholders’ equity, except the changes in paid-in capital and distributions to stockholders due to investments by stockholders.

 

Earnings Per Share

 

The Company computes earnings per share (“EPS”) following ASC Topic 260, “Earnings per share.” Basic EPS is measured as the income or loss available to common shareholders divided by the weighted average common shares outstanding for the period. Diluted EPS presents the dilutive effect on a per-share basis from the potential conversion of convertible securities or the exercise of options and or warrants; the dilutive impacts of potentially convertible securities are calculated using the as-if method; the potentially dilutive effect of options or warrants are computed using the treasury stock method. Potentially anti-dilutive securities (i.e., those that increase income per share or decrease loss per share) are excluded from diluted EPS calculation.

 

14

 

Fair Value Measurements of Financial Instruments

 

The Company’s financial instruments, including cash and equivalents, accounts and other receivables, accounts and other payables, accrued liabilities, and short-term debt, have carrying amounts that approximate their fair values due to their short maturities. ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosing the Company’s fair value of financial instruments. ASC Topic 825, “Financial Instruments,” defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  ● Level 1 - inputs to the valuation methodology used quoted prices for identical assets or liabilities in active markets.

 

  ● Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets and information that are observable for the asset or liability, either directly or indirectly, for substantially the financial instrument’s full term.

 

  ● Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

Lease

 

Effective December 31, 2018, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. 

  

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and it includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Share-based Compensation

 

The Company recognize share-based compensation expense on a straight-line basis over the applicable requisite service period, based on the grant date fair value of the award. The fair value of shares issued for services is calculated by multiplying the number of shares issued with the stock price on the grant date.

 

15

 

Commitments and Contingencies 

 

From time to time, the Company is a party to various legal actions arising in the ordinary course of business. The majority of these claims and proceedings related to or arise from commercial disputes. The Company first determines whether a loss from a claim is probable, and if it is reasonable to estimate the potential loss. The Company accrues costs associated with these matters when they become probable, and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Also, the Company discloses a range of possible losses, if a loss from a claim is probable but the amount of loss cannot be reasonably estimated, which is in line with the applicable requirements of Accounting Standard Codification 450. The Company’s management does not expect any liability from the disposition of such claims and litigation individually or in the aggregate would have a material adverse impact on the Company’s consolidated financial position, results of operations and cash flows.

 

Recent Accounting Pronouncements

 

In January 2025, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. This guidance amends the effective date of Update 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption of Update 2024-03 is permitted. The Company is currently in the process of evaluating the impact this amended guidance may have on the footnotes to its consolidated financial statements.

 

In November 2025, the FASB issued ASU 2025-08, Financial Instruments—Credit Losses (Topic 326): Purchased Loans. This update improves the decision usefulness of the financial reporting for acquired financial assets. The amendments require that purchased seasoned loans be accounted for using the gross-up approach, which will enhance comparability and consistency in the accounting for acquired financial assets. The amendments in this Update are effective for all entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. The Company is currently in the process of evaluating the impact this amended guidance may have on its consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. This update improves U.S. GAAP by establishing authoritative guidance on the accounting for government grants received by business entities. For public business entities, the amendments are effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. The Company is currently in the process of evaluating the impact this amended guidance may have on its consolidated financial statements.

 

In May 2026, the FASB issued ASU 2026-2, Environmental Credits and Environmental Credit Obligations (Topic 818). This Update provides recognition, measurement, presentation, and disclosure requirements for all entities that generate, purchase, or receive environmental credits or have a regulatory compliance obligation that may be settled with environmental credits. For public business entities, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. The Company is currently in the process of evaluating the impact this amended guidance may have on its consolidated financial statements.

 

In September 2026, the FASB issued ASU 2026-3, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. This Update improves the decision usefulness of investment company financial reporting by amending the guidance on how those entities determine the fair value of an equity security that is subject to a contractual restriction that prohibits the sale of that security. The amendments in this Update are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. The Company is currently in the process of evaluating the impact this amended guidance may have on its consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

16

 

3. Discontinued Operation

 

On April 30, 2025, the Board resolved to discontinue the operations of Shandong Yunchu. Subsequently, on September 1, 2025, the Company disposed of its 100% equity interest in Promising Prospect HK Limited (“Promising HK”) for nominal consideration. Promising HK holds the 100% equity interest in Shandong Yunchu through Jiayi Technologies and does not own any other operating assets of the Company.

 

On June 15, 2026, the Company completed the disposition of its 100% equity interest in Bless Chemical for nominal consideration. Bless Chemical held the 100% equity interest in Jingshan Sanhe Luckysky New Energy Technologies Co., Ltd. through Hubei Bulaisi and did not own any other operating assets of the Company.

 

The discontinued operation represents a strategic shift that has a major effect on the Company’s operations and financial results, which trigger discontinued operations accounting in accordance with ASC 205-20-45. Results of operations related to the discontinued operations for the nine months ended September 30, 2025 were retroactively reported as loss from discontinued operations. The results of discontinued operations for the nine months ended September 30, 2026 and 2025 are as follows:

 

    For the Nine Months Ended
September 30,
 
    2026     2025  
Net revenues   $ 58,064     $ 2,451,695  
Cost of revenues     57,636       2,417,537  
Gross profit     428       34,158  
                 
Operating expenses:                
Selling and marketing expenses     3,926       20,332  
General and administrative expenses     492,766       1,172,362  
Research and development expenses     18,605       53,888  
Total operating expenses     515,297       1,246,582  
                 
Loss from discontinued operations     (514,869 )     (1,212,424 )
                 
Other income (expenses)                
Interest income     4       133  
Interest expenses     (82,588 )     (99,957 )
Other income     -       7,252  
Other expenses     (29,631 )     (41,324 )
Gain on disposal of subsidiaries     235,815       (8,627,916 )
Total other income (expenses)     123,600       (8,761,812 )
                 
Loss before income taxes     (391,269 )     (9,974,236 )
Income taxes provision     -       -  
Net loss from discontinued operations   $ (391,269 )   $ (9,974,236 )

 

17

 

Assets and liabilities of the discontinued operations:

 

    As of
December 31,
 
    2025  
CURRENT ASSETS:      
Cash   $ 103,205  
Accounts receivable, net     74,876  
Inventories, net     138,706  
Advances to suppliers, net     946,947  
Other receivables, net     572  
Other receivables-related parties     3,854,414  
Prepaid expenses     20,050  
TOTAL CURRENT ASSETS     5,138,770  
         
NON-CURRENT ASSETS:        
Plant and equipment, net     1,933,555  
Long-term investments     8,068  
TOTAL ASSETS   $ 7,080,393  
         
CURRENT LIABILITIES:        
Loans-current   $ 5,183,252  
Accounts payable     592,016  
Advance from customers     62,200  
Taxes payable     96,155  
Other payables     325,552  
Other payables-related parties     100,099  
TOTAL CURRENT LIABILITIES     6,359,274  
         
NON-CURRENT LIABILITIES        
Loans-noncurrent     428,994  
TOTAL LIABILITIES   $ 6,788,268  

 

4. Accounts Receivable, Net

 

The Company extends credit terms of 15 to 60 days to the majority of its domestic customers, which include third-party distributors, supermarkets, and wholesalers.

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
Trade accounts receivable   $1,144,204     $918,569  
Less: Allowance for credit losses     (894,193 )     (784,239 )
    $ 250,011     $ 134,330  
Allowance for credit losses                
Beginning balance   $ (784,239 )   $ (745,194 )
Additions to allowance     (109,954 )     (39,045 )
Ending balance   $ (894,193 )   $ (784,239 )

 

18

 

The following table summarizes the Company’s accounts receivable by aging bucket:

 

    As of  
Accounts Receivable by aging bucket   September 30,
2026
    December 31,
2025
 
Less than 3 months   $ 34,223     $ 138,422  
From 4 to 6 months     568       573  
From 7 to 12 months     304,060       1,098  
From 1 to 2 years     2,417       3,005  
From 2 to 3 years     3,956       7,140  
Over 3 years     798,980       768,331  
Total gross accounts receivable     1,144,204       918,569  
Allowance for doubtful accounts     (894,193 )     (784,239 )
Accounts Receivable, net   $ 250,011     $ 134,330  

 

5. Advances to Suppliers, Net

 

Prepayments mainly include advance payment to suppliers and vendors to procure raw materials. Prepayments consist of the following:

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
Payment to suppliers and vendors   $ 124,722     $ 40,153  
Allowance for credit losses     (2,643 )     (2,534 )
Total   $ 122,079     $ 37,619  

 

6. Inventories, Net

 

Inventories consisted of the following as of September 30, 2026 and December 31, 2025:

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
Raw materials   $ 1,092,525     $ 1,049,598  
Work in progress     1,129,396       1,216,965  
Finished goods     303,662       291,053  
Allowance for inventory reserve     (2,042,650 )     (1,958,352 )
Total   $ 482,933     $ 599,264  

 

19

 

7. Other Receivables, Net

 

Other receivables, net consist of the following:

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
Borrowing to third party companies for their general working capital needs   $   1,491,536     $ -  
Guarantee deposit          137,952         132,259  
Advance to employees as petty cash to cover minor expenses of the Company            16,051             5,355  
Rental deposit              8,860       -  
Others          104,379           88,633  
Allowance for credit losses     (237,459 )     (225,209 )
Total   $   1,521,319     $       1,038  

 

8. Plant and Equipment, Net

 

Plant and equipment consisted of the following as of September 30, 2026 and December 31, 2025:

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
At Cost:            
Buildings   $ 3,949,961     $ 3,704,171  
Machinery and equipment     1,189,648       1,127,968  
Office equipment     100,516       89,380  
Motor vehicles     142,867       150,949  
      5,382,992       5,072,468  
Less: Accumulated depreciation     (2,763,197 )     (2,353,051 )
      2,619,795       2,719,417  
Construction in progress     -       23,909  
    $ 2,619,795     $ 2,743,326  

 

Depreciation expense for the three months ended September 30, 2026 and 2025 was $157,371 and $77,631, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was $318,323 and $231,466, respectively.

  

9. Intangible Assets

 

    As of  
    September 30,
2026
    December 31,
2025
 
    Unaudited        
At Cost:            
Land use rights   $ 780,628     $ 748,412  
Software licenses     51,322       52,980  
Trademark     931,464       893,023  
      1,763,414       1,694,415  
Less: Accumulated amortization     (1,067,145 )     (985,172 )
    $ 696,269     $ 709,243  

 

Amortization expense for the three months ended September 30, 2026 and 2025 was $8,548 and $33,429, respectively. Amortization expense for the nine months ended September 30, 2026 and 2025 was $42,762 and $99,396, respectively.

 

20

 

As of September 30, 2026, the estimated future amortization expenses of the intangible assets were as follow:

 

Twelve months ending September 30,   Amortization
expenses
 
2027   $ 33,938  
2028     33,938  
2029     17,532  
2030     16,040  
2031     16,040  
Thereafter     578,781  
Total   $ 696,269  

 

10. Other Payables

 

As of September 30, 2026 and December 31, 2025, the balance of other payable was $2,048,965 and $1,810,202 respectively. Other payables – third parties are those non-trade payables arising from transactions between the Company and certain third parties. 

 

11. Advance from Customer

 

For our operations, the proceeds received from sales are initially recorded as advances from customers, which are usually related to unsatisfied performance obligations at the end of an applicable reporting period. As of September 30, 2026 and December 31, 2025, the outstanding balance of the advance from customers was $324,674 and $150,927 respectively. Due to the generally short-term duration of the relevant contracts, most of the performance obligations are satisfied in the following reporting period.

 

12. Related Party Transactions

 

As of September 30, 2026 and December 31, 2025, amounts due from related parties were $nil and $6,385, respectively. The balance as of December 31, 2025 consisted of a nontrade receivable from Mr. Yong Yang, a member of management of Fast Approach. The balance was unsecured, non-interest bearing and due on demand.

  

As of September 30, 2026 and December 31, 2025, the outstanding balance due to related parties was $3,448,165 and $2,948,824, respectively. During the nine months ended September 30, 2026, the Company received advances of $449,076 from related parties for working capital purposes. Such advances are included in the balance due to related parties as of September 30, 2026. The balances represent advances for working capital needs of the Company, and are non-interest bearing and unsecured unless otherwise disclosed herein.

 

Outstanding balances of significant parties are stated below:

 

        As of  
Amounts due to related parties:       September 30, 2026     December 31,
2025
 
        Unaudited        
Mr. Bin Zhou   Chief Executive Officer and Chairman of the Company   $ 3,109,174     $ 1,753,118  
Ms. Luojie Pu   Independent director of the Company; pursuant to a tripartite agreement dated March 20, 2026 among the Company, Ms. Luojie Pu and Mr. Bin Zhou, the balance owed to Ms. Luojie Pu was transferred to Mr. Bin Zhou.     -       872,803  
Ms. Huiying Jin   the management of the Xianning Bozhuang     317,690       304,580  
Ms. Ye Zhang   the management of the Shanghai Shuning     -       18,323  
Mr. Yong Yang   the management of Fast Approach     21,301       -  
Total       $ 3,448,165     $ 2,948,824  

 

21

 

13. Goodwill

 

The changes in the carrying amount of goodwill are as follows: 

 

    Hubei
Shengsili
(1)
    Hubei
Keqibang
(2)
    Total  
Balance as of December 31, 2025   $ 7,005     $ -     $ 7,005  
Goodwill acquired     -       19,836       19,836  
Foreign currency translation adjustments     301       -       301  
Balance as of September 30, 2026   $ 7,306     $ 19,836     $ 27,142  

 

(1) On November 26, 2025, Bozhuang entered into a Share Purchase Agreements with shareholders of Hubei Shengsili, to acquire 67% of the equity interests in Hubei Shengsili for consideration of $145.

  

(2) On September 24, 2026, Hubei Taihe entered into a Share Purchase Agreements with shareholders of Hubei Keqibang Technology Co., Ltd. (“Hubei Keqibang”), to acquire 100% equity interests in Hubei Keqibang for a consideration of $19,836.

  

14. Bank Loans

 

The outstanding balances on short-term and long-term bank loans consisted of the following:

 

              As of  
Lender   Maturities   Interest rate     September 30,
2026
    December 31,
2025
 
              Unaudited        
Chajiaduo Supply Chain Hubei Co., Ltd.   Due in February 2026     -       -       71,499  
Mr. Wei Jin   Due in December 2025     12 %     -       71,499  
Bank overdraft                 5,446       785  
Total               $ 5,446     $ 143,783  

 

The loan from Chajiaduo Supply Chain Hubei Co., Ltd. was obtained to support general working capital, with no guarantee requirement. This loan was fully repaid upon maturity.

 

The loan from Mr. Wei Jin was obtained to support general working capital, with no guarantee requirement. This loan was fully repaid in March 2026.

 

Interest expense for the three months ended September 30, 2026 and 2025 was $295 and $3,916, respectively. Interest expense for the nine months ended September 30, 2026 and 2025 was $1,031 and $8,180, respectively.

 

22

 

15. Operating lease

 

The Company leases office spaces in Wuhan City, Hubei Province and Shanghai City of China, with terms of two years. The Company considers those renewal or termination options that are reasonably certain to be exercised in the determination of the lease term and initial measurement of right of use assets and lease liabilities. Leases with initial term of 12 months or less are not recorded on the balance sheet.

 

The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company discounts lease payments based on an estimate of its incremental borrowing rate.

 

The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

 

The table below presents the operating lease related assets and liabilities recorded on the balance sheets:

 

    As of  
    September 30,
2026
    December 31,
2025
 
Operating lease assets:                
Operating lease right of use assets   $ 78,948     $           -  
Total operating lease assets     78,948       -  
                 
Operating lease obligations:                
Current operating lease liabilities     48,764       -  
Non-current operating lease liabilities     27,031       -  
Total operating lease obligations   $ 75,795     $ -  

 

The weighted-average remaining lease term and the weighted-average discount rate of leases are as follows:

 

    September 30,
2026
 
Weighted-average remaining lease term     1.6 years  
         
Weighted-average discount rate     3.00 %

 

The following table summarizes the maturity of operating lease liabilities as of September 30, 2026:

 

Twelve months ending September 30,   US$  
2027   $ 50,272  
2028     27,250  
Total lease payments     77,522  
Less: imputed interest     (1,727 )
Total lease liabilities   $ 75,795  

 

23

 

16. Equity

 

On September 9, 2025, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to increase the total number of shares of all classes of stock which the Company has authority to issue to 1,600,000,000 consisting of (a) 1,500,000,000 shares of common stock, par value $0.001 per share, and (b) 100,000,000 shares of preferred stock, par value $0.001 per share, to be issued from time to time with such rights, preferences and priorities as the Board of Directors shall designate.

 

On August 29, 2025, the stockholders of the Company approved the 2025 Equity Incentive Plan (the “2025 Plan”), which provides that up to 7,000,000 shares of common stock, par value $0.001 per share, may be issued pursuant to grants of equity-based awards under the 2025 Plan. During the year ended December 31, 2025, the Company issued an aggregate of 6,950,000 shares of common stock to nine employees under the 2025 Plan for a fair value of $14,429,500. The fair value is determined based on the stock price on the grant date.

 

As of September 30, 2026 and December 31, 2025, the number of common shares issued and outstanding was 14,232,714.

 

17. Earnings (Loss) Per Share

 

    For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
    Unaudited     Unaudited     Unaudited     Unaudited  
Loss from continuing operations   $ (367,311 )   $ (3,083,964 )   $ (646,686 )   $ (3,744,540 )
Loss from discontinued operations   $ (24,348 )   $ (9,064,329 )   $ (391,269 )   $ (9,974,236 )
                                 
Loss per share from continuing operations - Basic and diluted   $ (0.03 )   $ (0.42 )   $ (0.05 )   $ (0.51 )
Loss per share from discontinued operations-Basic and diluted   $ 0.00     $ (1.24 )   $ (0.03 )   $ (1.37 )
Basic and diluted weighted average shares outstanding     14,232,714       7,282,714       14,232,714       7,282,714  

  

18. Concentrations

 

Customers Concentrations:

 

The following table sets forth information about each customer that accounted for 10% or more of the Company’s revenues for the nine months ended September 30, 2026 and 2025.

 

    For the Nine Months Ended September 30,  
    2026     2025  
Customers   Amount     %     Amount     %  
A   $ -       -     $  17,083       25  
B   $ -       -     $    7,577       11  
C   $ 4,656,965       49     $ -       -  
D   $ 1,621,772       17     $ -       -  
E   $ 1,286,280       13     $ -       -  

 

24

 

Suppliers Concentrations

 

The following table sets forth information about each supplier that accounted for 10% or more of the Company’s purchase for the nine months ended September 30, 2026 and 2025.

 

    For the Nine Months Ended September 30,  
    2026     2025  
Suppliers   Amount     %     Amount     %  
A   $ -       -     $ 1,365       99  
B   $ 2,335,352       29     $ -       -  
C   $ 1,398,554       18     $ -       -  
D   $ 1,263,127       16     $ -       -  
E   $ 1,037,934       13     $ -       -  
F   $  949,178       12     $ -       -  

 

19. Credit risk

 

The Company’s deposits are made with banks located in the PRC. Cash maintained in banks within the People’s Republic of China of less than RMB0.5 million (equivalent to $74,577) per bank are covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China. As of September 30, 2026 and December 31, 2025, the Company had $35,460 and $24,691, respectively, in cash balances held at PRC financial institutions that exceeded the applicable insured limits. There is no cash balance held at American financial institutions that exceeded the applicable insured limits as of September 30, 2026 and December 31, 2025.

 

20. Contingencies

 

The Company records accruals for certain of its outstanding legal proceedings or claims when it is probable that liability will be incurred and the amount of loss can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal proceedings or claims that could affect the amount of any accrual, as well as any developments that would make a loss contingency both probable and reasonably estimable. The Company discloses the amount of the accrual if it is material.

 

When a loss contingency is not both probable and estimable, the Company does not record an accrued liability but discloses the nature and the amount of the claim, if material. However, if the loss (or an additional loss in excess of the accrual) is at least reasonably possible, then the Company discloses an estimate of the loss or range of loss, unless it is immaterial or an estimate cannot be made. The assessment of whether a loss is probable or reasonably possible, and whether the loss or a range of loss is estimable, often involves complex judgments about future events. Management is often unable to estimate the loss or a range of loss, particularly where (i) the damages sought are indeterminate, (ii) the proceedings are in the early stages, or (iii) there is a lack of clear or consistent interpretation of laws specific to the industry-specific complaints among different jurisdictions. In such cases, there is considerable uncertainty regarding the timing or ultimate resolution of such matters, including eventual loss, fine, penalty or business impact, if any. The Company has analyzed its operations subsequent to September 30, 2026 to the date these unaudited condensed consolidated financial statements were issued and has determined that it does not have any material contingency events to disclose.

 

25

 

21. Subsequent Events 

 

The Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued. There are two types of subsequent events: (1) recognized, or those that provide additional evidence with respect to conditions that existed at the dates of the balance sheets, including the estimates inherent in the process of preparing financial statements, and (2) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date. The Company has analyzed its operations subsequent to September 30, 2026 to the date these unaudited condensed consolidated financial statements were issued, and has determined that other than described below, it does not have any material subsequent events to disclose.

 

On October 2, 2026, the Company entered into an ATM Sales Agreement (the “Sales Agreement”) with Craft Capital Management LLC (the “Agent”), pursuant to which the Agent acts as the Company’s sales agent in connection with the offer and sale of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In accordance with the terms of the Sales Agreement, the Company may offer and sell shares of its Common Stock (the “Shares”) from time to time through or to the Agent, acting as sales agent or principal.

 

The aggregate market value of our outstanding Common Stock held by non-affiliates, or our public float, was approximately $67.6 million, based on 11,638,514 outstanding Shares held by non-affiliates and a per Share price of $5.81, the closing price of our Shares on August 11, 2026. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding one-third of our “public float” (i.e., the aggregate market value of our Common Stock held by our non-affiliates), or approximately $22,539,922, in any 12-month period so long as our public float remains below $75,000,000. In November 2026, the Company received $17,000 in net proceeds from the sale of stock under our at-the-market program.

 

26

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

We are headquartered in Flushing, New York. After a series of acquisitions and dispositions in 2026 and 2025, our primary business, which is carried out by Xianning Bozhuang, Hubei Shengsili, Shanghai Shuning, Xianning Huarui and Fast Approach Inc, includes the following operations:

 

  ● Manufacture and distribute black tea and green tea products; and
     
  ● Online advertising services.

 

Recent Development

 

We have entered into commercial operations to source, market and distribute lactoferrin, a critical glycoprotein used in a wide range of health products, including our chewable immune tablets. Lactoferrin is also widely used in infant formulas, sports nutrition, and a wide range of dietary and immune supplements. The date these unaudited condensed consolidated financial statements were issued.

 

To improve access to this fast-growing market, we intend to expand our executive team to include a Chief Scientist. This newly added role will play a key role in sourcing and prioritizing strategic scientific investments, joint ventures and new product launches with a goal to expand and enhance our product portfolio and revenue generating capabilities. We have identified a strong leading candidate at a leading US academic institution for this Chief Scientist role and is in advanced negotiations to fill the role in the near term.

 

Results of Operations

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025.

 

The following discussion should be read in conjunction with the Company’s unaudited condensed consolidated financial statements for the three months ended September 30, 2026 and 2025 and related notes.

 

    Three Months Ended     Increase /     Increase /  
    September 30,     Decrease     Decrease  
(In Thousands of USD)   2026     2025     ($)     (%)  
Net revenues     2,493       4       2,489       62,225  
Cost of revenues     (2,412 )     (2 )     (2,410 )     120,500  
Gross profit     81       2       79       3,950  
Operating expenses:                                
Selling and marketing expenses     4       3       1       33  
General and administrative expenses     425       3,068       (2,643 )     (86 )
Operating loss     (348 )     (3,069 )     2,721       (89 )
Interest expense     -       (4 )     4       (100 )
Other expense     (19 )     -       (19 )     -  
Loss before tax     (367 )     (3,073 )     2,706       (88 )
Income tax expense     -       (11 )     11       (100 )
Loss from continuing operations     (367 )     (3,084 )     2,717       (88 )
Income (loss) from discontinued operations     (25 )     (9,064 )     9,039       (100 )
Net loss     (392 )     (12,148 )     11,756       (97 )

 

Net Revenues. Our net revenues for the three months ended September 30, 2026 amounted to $2,493,318, reflecting an increase of $2,489,714 compared to $3,604 for the three months ended September 30, 2025. This increase was attributable to the growth of our online advertising business for the three months ended September 30, 2026.

 

Cost of Revenues. During the three months ended September 30, 2026, we experienced an increase in our cost of revenue of $2,410,705, in comparison to the three months ended September 30, 2025, from $1,761 to $2,412,466. This increase was mainly due to an increase in cost of revenue from our online advertising services.

 

27

 

Gross Profit. Our gross profit increased by $79,009, to $80,852 for the three months ended September 30, 2026 compared to profit of $1,843 for the three months ended September 30, 2025. Our gross margin was 3.2% for the three months ended September 30, 2026 compared to 51.1% for the three months ended September 30, 2025. The increase in gross profit and decrease in gross margin was attributable to the growth of our online advertising business with lower gross profit.

 

Operating Expenses

 

Selling and Marketing Expenses. Our selling and marketing expenses increased by $516, to $3,908 for the three months ended September 30, 2026 from $3,392 for the three months ended September 30, 2025. This increase was mainly due to the increase in shipping and delivery expenses and business travel and meals expense.

 

General and Administrative Expenses. Our general and administrative expenses for the three months ended September 30, 2026 decreased by $2,642,538, to $424,643 compared to $3,067,181 for the three months ended September 30, 2025. This decrease was mainly due to the issuance of 1,450,000 shares of common stock under the 2025 Plan for a fair value of $2.80 million during the three months ended September 30, 2025, and no shares were issued during the three months ended September 30, 2026. 

 

Research and Development Expenses. Our research and development expenses for the three months ended September 30, 2026 was $115, compared to $nil for the three months ended September 30, 2025. This increase was mainly due to an increase in research expense of our new products. 

 

Net Loss

 

Our net loss was $391,659 for the three months ended September 30, 2026, compared to a net loss of $12,148,293 for the three months ended September 30, 2025. This change in net loss was primarily attributable to the decrease in stock based compensation expense of $2.80 million, and loss from discontinued operations of $9,039,981. On September 1, 2025, the Company disposed of its 100% equity interest in Promising HK, Shandong Yunchu and Jiayi Technologies for nominal consideration. Operating results of Jingshan Sanhe and Hubei Bulaisi was reclassified as loss from discontinued operations for the three months ended September 30, 2025.

 

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025.

 

The following discussion should be read in conjunction with the Company’s unaudited condensed consolidated financial statements for the nine months ended September 30, 2026 and 2025 and related notes.

 

    Nine Months Ended     Increase /     Increase /  
    September 30,     Decrease     Decrease  
(In Thousands of USD)   2026     2025     ($)     (%)  
Net revenues     9,584       67       9,517       14,204  
Cost of revenues     (3,532 )     (10 )     (3,522 )     35,220  
Promotion cost     (5,145 )     -       (5,145 )     -  
Gross profit     907       57       850       1,491  
Operating expenses:                                
Selling and marketing expenses     15       11       4       36  
General and administrative expenses     1,509       3,766       (2,257 )     (60 )
Research & Developing expenses     1       -       1       -  
Operating loss     (618 )     (3,720 )     3,102       (83 )
Interest expense     (1 )     (8 )     7       (88 )
Other expense     (19 )     (6 )     (13 )     217  
Loss before tax     (638 )     (3,734 )     3,096       (83 )
Income tax expense     (9 )     (11 )     2       (18 )
Loss from continuing operations     (647 )     (3,745 )     3,098       (83 )
Loss from discontinued operations     (391 )     (9,974 )     9,583       (96 )
Net loss     (1,038 )     (13,719 )     12,681       (92 )

 

Net Revenues. Our net revenues for the nine months ended September 30, 2026 amounted to $9.58 million, reflecting an increase of approximately $9.52 million compared to $67,270 for the nine months ended September 30, 2025. This increase was attributable to our acquisition of Hubei Shengsili in November 2025 and the expanded enterprise sales distribution channel of our tea products, as well as the growth of our online advertising business for the nine months ended September 30, 2026.

 

28

 

Cost of Revenues. During the nine months ended September 30, 2026, we experienced an increase in our cost of revenue of $3.52 million, in comparison to the nine months ended September 30, 2025, from $9,724 to $3.53 million. This increase was mainly due to an increase in cost of revenue from sales of tea products and online advertising business. 

 

Promotion cost. During the nine months ended September 30, 2026, we incurred promotion cost of $5.15 million in connection with sales of tea products by Hubei Shengsili, compared to $nil for the nine months ended September 30, 2025.

 

Gross Profit. Our gross profit increased by approximately $0.85 million, to $0.91 million for the nine months ended September 30, 2026 compared to $57,546 for the nine months ended September 30, 2025. Our gross margin decreased to 9.5% for the nine months ended September 30, 2026 compared to 85.5% for the nine months ended September 30, 2025. The increase in gross profit and decrease in gross margin was attributable to our acquisition of Hubei Shengsili, which engaged sales agents to expand the sales network of our tea product, incurred significant promotion cost to achieve small profits but quick turnover, as well as the growth of our online advertising business with lower gross margin.

 

Operating Expenses

 

Selling and Marketing Expenses. Our selling and marketing expenses increased by $3,203, to $14,610 for the nine months ended September 30, 2026 from $11,407 for the nine months ended September 30, 2025. This increase was mainly due to the increase in shipping and delivery expenses and business travel and meals expense.

 

General and Administrative Expenses. Our general and administrative expenses for the nine months ended September 30, 2026 decreased by approximately $2.26 million, to $1.51 million compared to $3.77 million for the nine months ended September 30, 2025. This decrease was mainly due to the issuance of 1,450,000 shares of common stock under the 2025 Plan for a fair value of $2.80 million during the nine months ended September 30, 2025, and no shares were issued during the nine months ended September 30, 2026. 

 

Research and Development Expenses. Our research and development expenses for the nine months ended September 30, 2026 was $1,069 compared to $nil for the nine months ended September 30, 2025. This increase was mainly due to an increase in research expense of our new products.

 

Net Loss

 

Our net loss was $1.04 million for the nine months ended September 30, 2026, compared to $13.72 million for the nine months ended September 30, 2025. This change in net loss was primarily attributable to the increase in revenue, and decrease in stock based compensation expense of $2.80 million, and loss from discontinued operations. We completed the disposition of our 100% equity in Bless Chemical, which owned Hubei Bulaisi and Jingshan Sanhe, on June 15, 2026. Operating results of Jingshan Sanhe and Hubei Bulaisi was reclassified as loss from discontinued operations for the nine months ended September 30, 2025.

 

Foreign Exchange Controls

 

A significant portion of our cash is held in RMB by our PRC subsidiaries. The RMB is not freely convertible into foreign currencies. Under the PRC’s foreign exchange regulations, payments of current account items, including profit distributions, interest payments, and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior approval from the State Administration of Foreign Exchange (“SAFE”) by complying with certain procedural requirements. However, approval from or registration with appropriate government authorities is required where RMB is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated in foreign currencies. These restrictions could affect our ability to utilize our PRC cash balances to fund our offshore operations or to make dividends or other distributions to our holding company.

 

29

 

Liquidity and Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern; however, the Company has reported net loss from continuing operations of $646,686 for the nine months ended September 30, 2026, and its net cash provided by operating activities from continuing operations for the nine months ended September 30, 2026 was $129,316. The Company had an accumulated deficit of $176,077,537 and a working capital deficit of $6,457,436 as of September 30, 2026. 

 

These factors raise substantial doubt on the Company’s ability to continue as a going concern. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company has recently expanded its sales and marketing efforts by engaging sales agents to promote its tea products and enhance market penetration. The Company believes this sales agent model enables it to improve its profit and cash flow. Management’s plan for the Company’s continued existence is dependent upon management’s ability to execute its business plan and generate additional profits, Additionally, Management may need to continue to rely on private placements or other capital raising transactions or certain related parties to provide funding for investment, for working capital and general corporate purposes. If management is unable to execute its plan, the Company may become insolvent.

 

On October 2, 2026, the Company entered into an ATM Sales Agreement (the “Sales Agreement”) with Craft Capital Management LLC (the “Agent”), pursuant to which the Agent acts as the Company’s sales agent in connection with the offer and sale time-to-time of shares of the Company’s common stock, having an aggregate gross sales price of an aggregate of up to $22.5 million. In November 2026, the Company received $17,000 in net proceeds from the sale of stock under our at-the-market program.

 

The following table provides detailed information about our net cash flow for all financial statement periods presented in this report.

 

Cash Flows Data:

 

    For the Nine Months Ended
September 30
 
(In thousands of U.S. dollars)   2026     2025  
Net cash flows used in operating activities     (375 )     (1,326 )
Net cash flows used in investing activities     (101 )     (2 )
Net cash flows provided by financing activities     812       1,200  

 

Operating Activities

 

Net cash used in operating activities was $375,385 during the nine months ended September 30, 2026, primarily due to net loss from continuing operations of $646,686, adjustments to reconcile net loss of $456,947, changes in net operating assets and liabilities of $319,055, and net cash used in operating activities from discontinued operations of $504,701.

 

Net cash used in operating activities was $1,325,507 during the nine months ended September 30, 2025, primarily due to net loss from continuing operations of $3,744,540, adjustments to reconcile net loss of $3,162,013, changes in net operating assets and liabilities of $227,621, and net cash used in operating activities from discontinued operations of $970,601.

 

Investing Activities

 

Net cash used in investing activities from continuing operations for the nine months ended September 30, 2026 was $101,183, primarily due to cash used for purchase of equipment of $82,124, and acquisition of subsidiaries of $19,499. Net cash provided by investing activities from discontinued operations for the nine months ended September 30, 2026 was $325.

 

Net cash used in investing activities from continuing operations for the nine months ended September 30, 2025 was $nil. Net cash used in investing activities from discontinued operations for the nine months ended September 30, 2025 was $2,474.

 

Financing Activities

 

The net cash provided by financing activities from continuing operations was $307,278 during the nine months ended September 30, 2026, mainly attributed to proceeds from related parties of $449,076, repayment of bank loans of $146,608. Net cash provided by financing activities from discontinued operations for the nine months ended September 30, 2026 was $504,376.

 

The net cash provided by financing activities from continuing operations was $323,525 during the nine months ended September 30, 2025, mainly attributed to proceeds from related parties of $323,740. Net cash provided by financing activities from discontinued operations for the nine months ended September 30, 2025 was $876,006.

 

30

 

Critical Accounting Estimates and Policies

 

The preparation of financial statements in conformity with the United States generally accepted accounting principles requires our management to make assumptions, estimates, and judgments that affect the amounts reported in the financial statements, including the notes to that, and related disclosures of commitments contingencies, if any.

 

Accounts receivable, net

 

Accounts receivable is presented net of an allowance for credit losses. In determining the amount of the allowance for credit losses, we consider historical collectability based on past due status, the age of the accounts receivable balances, credit quality of the customers based on ongoing credit evaluations, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect our ability to collect from customers. Accounts receivable is written off after all collection efforts have ceased. As of September 30, 2026 and December 31, 2025, our allowance for uncollectable balances amounted to $894,193 and $784,239, respectively.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective due to material weaknesses in our internal control over financial reporting, as reported in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

 

As a result, we performed additional analysis as deemed necessary to ensure that our unaudited condensed consolidated financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the unaudited condensed consolidated financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control Over Financial Reporting

 

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

31

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On July 27, 2023, Daqi Cui, a former employee, filed a complaint against the Company in Queens County, the Supreme Court of the State of New York, asserting claims of breach of employment contract, seeking $609,145.05 in damages as well as attorneys’ fees and costs. On November 6, 2023, the Company filed a motion to move the case to the United States District Courthouse, Eastern District of New York for an Order to dismiss with prejudice. On July 29, 2024, the complaint was dismissed by the Eastern District of New York. However, Plaintiff was granted leave to file an amended complaint within 30 days after entry of the order. Subsequently, the Plaintiff filed an amended complaint against the Company and the Company has moved to dismiss the amended complaint. On July 21, 2025, the motion to dismiss was denied by the Court.

 

On July 31, 2025, the Company filed an Answer to the amended complaint and asserted a counterclaim against the Plaintiff. The case subsequently proceeded to the discovery phase. In March and April 2026, the Plaintiff filed a motion to compel and a motion for sanctions. Concurrently, in April 2026, the Plaintiff’s counsel filed a motion to withdraw as attorney, which resulted in the Court terminating certain deadlines and hearings pending resolution of the withdrawal motion. The Company intends to continue to vigorously defend against the Plaintiff’s claims and pursue its counterclaim.

 

As a commercial enterprise, the Company is subject to various claims and legal actions in the ordinary course of business. These matters include commercial disputes arising in the course of its business. The Company is not aware of any pending or threatened litigation that it believes is reasonably likely to have a material adverse effect on its results of operations, financial position or cash flows. See Note 19, “Contingencies,” to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information regarding legal proceedings and related contingencies.

 

ITEM 1A. RISK FACTORS

 

Risk Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the Company’s registration statement on Form S3/A as filed with the SEC on April 2, 2026. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Company’s registration statement Form S3/A as filed with the SEC on April 2, 2026.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Not applicable. 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

(a) Not applicable.

 

(b) Not applicable.

 

(c) During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

 

32

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of this report.

 

Exhibit No.   Description
10.1   ATM Sales Agreement dated October 2, 2026, by and between Planet Green Holdings Corp., and Craft Management LLC (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K filed October 2, 2026).
31.1   Certification of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2   Certification of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

* Filed herewith.

 

** Furnished herewith.

 

33

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PLANET GREEN HOLDINGS CORP.
   
Date: November 13, 2026 By: /s/ Bin Zhou
    Bin Zhou, Chief Executive Officer and Chairman
    (Principal Executive Officer)

 

Date: November 13, 2026 By: /s/ Wei Li
    Wei Li, Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this quarterly report has been signed by the following persons in the capacities and on the dates indicated.

 

34